Hong Fang Song

Insider Reports History

Location
Irvine, CA
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for Hong Fang Song
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hong Fang Song:

Company Role Class Num Shares Value Price $ Report Date Ownership
CG Oncology, Inc. Director Common Stock 2,903,931 $84,184,959 $28.99 03 Sep 2025 By Charming Jade Limited
CG Oncology, Inc. Director Common Stock 2,934,236 $80,984,913 $27.60 03 Sep 2025 By Chaming Jade Limited
CG Oncology, Inc. Director Common Stock 613,928 $16,152,445 $26.31 03 Sep 2025 Direct
CG Oncology, Inc. Director Common Stock 586,982 $15,443,496 $26.31 03 Sep 2025 By Unique Diamond Investments Limited
CG Oncology, Inc. Director Director Stock Option (right to buy) 24,165 05 Jun 2025 Direct
CG Oncology, Inc. Director Stock Option (Right to Buy) 15,600 04 Oct 2024 Direct

Insider Reports Filed by Hong Fang Song

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CGON CG Oncology, Inc. 03 Sep 2025 4 -$2,779,542 4 Director 04 Sep 2025, 17:00
CGON CG Oncology, Inc. 05 Jun 2025 1 $0 4 Director 06 Jun 2025, 17:00
CGON CG Oncology, Inc. 16 Dec 2024 1 -$19,600,000 4 Director 17 Dec 2024, 18:03
CGON CG Oncology, Inc. 04 Oct 2024 1 $0 4 Director 07 Oct 2024, 17:03
CGON CG Oncology, Inc. 29 Aug 2024 2 -$23,000,089 4 Director 30 Aug 2024, 19:18
CGON CG Oncology, Inc. 29 Jan 2024 8 +$4,999,983 4 Director 31 Jan 2024, 16:30
CGON CG Oncology, Inc. 24 Jan 2024 0 $0 3 Director, 10%+ Owner 24 Jan 2024, 21:01